LTFS
MRSN

Ladenburg Thalmann Financial Services’s Mersana Therapeutics MRSN Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$3K Hold
18
– – ﹤0.01% 4968
2019
Q3 		$1K Hold
18
– – ﹤0.01% 5128
2019
Q2 		$2K Hold
18
– – ﹤0.01% 4982
2019
Q1 		$2K Hold
18
– – ﹤0.01% 4949
2018
Q4 		$2K Hold
18
– – ﹤0.01% 4903
2018
Q3 		$5K Buy
+18
New +$6.03K ﹤0.01% 4602

Other funds holding MRSN

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ladenburg Thalmann Financial Services's MRSN Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Mersana Therapeutics (MRSN) position steady in Q4 2019 at 18 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #4968.

Ladenburg Thalmann Financial Services first reported a position in MRSN in Q3 2018 and has held it in 6 quarters since. The position peaked at $5K in Q3 2018. 69 funds tracked by Wall St. Rank hold MRSN as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 18 shares of Mersana Therapeutics worth $3K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Mersana Therapeutics share count unchanged in Q4 2019.
  • Mersana Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4968 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Mersana Therapeutics in Q3 2018 and has held it in 6 quarters since.
  • Ladenburg Thalmann Financial Services's Mersana Therapeutics position peaked at $5K in Q3 2018.
  • 69 funds tracked by Wall St. Rank held Mersana Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.